跳至主要内容
临床试验/IRCT20221216056833N1
IRCT20221216056833N1尚未招募4 期

Evaluation of the efficacy of Noushin-Shahd-herbal-syrup on markers of liver function, inflammation and oxidative stress in patients with non-alcoholic fatty liver disease; a double blind randomized clinical trial study

Kerman University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • Age between 30 and 65 years
  • Consistency of exercise program
  • Body mass index less than 40
  • Not having a specific disease
  • Not drinking alcohol

排除标准

  • Performing CABG surgery, occurrence of ASC, heart and brain stroke, pulmonary embolism, deep vein thrombosis or TIA in the last 1 year
  • Taking anti-inflammatory drugs such as aspirin with an anti-inflammatory dose, antioxidant supplements, vitamins and omega-3 capsules (<1 g/day), and immunosuppressive drugs in the last three months
  • Presence of cancer, liver and thyroid diseases
  • alcohol consumption
  • Taking drugs that lower blood cholesterol and triglycerides

研究者

相似试验

The effect of Noshin Shahd herbal syrup on liver... | 临床试验